ALTIMMUNE, INC. Line of Credit Facility, Interest Rate During Period
ALTIMMUNE, INC. (ALT) reported Line of Credit Facility, Interest Rate During Period of 8.00% for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityInterestRateDuringPeriod · last filed 2019-04-01
- ALTIMMUNE, INC. line of credit facility, interest rate during period for fiscal 2018 was 8.00%.
| Period end | Line of Credit Facility, Interest Rate During Period 12 month |
|---|---|
| 2018-12-31 | 8.00% 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |